News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ITI Life Sciences Launches New R&D Program: £5.5 Million To Develop New Predictive Safety Models For Early Drug Development


10/19/2005 5:12:51 PM

ITI Life Sciences (Dundee, Scotland), together with CXR Biosciences (Dundee) and Artemis Pharmaceuticals (Cologne, Germany), today announces the launch of a new £5.5 million R&D programme to develop new screening and safety models to more accurately predict the effects of drug compounds and their breakdown products in the human body.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES